Suspension of trading
Centessa Pharmaceuticals plc Share Price
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 24/06/2026 am IST
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 24/06 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 24/06 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 626.65Cr 536.54Cr 500.6Cr 459.35Cr 863.14Cr 60TCr 880.13Cr 5.94TCr 2.32TCr 30TCr 2.35TCr 2.3TCr 99TCr | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 609.03Cr 521.45Cr 486.53Cr 446.43Cr 838.88Cr 58TCr 855.39Cr 5.77TCr 2.25TCr 29TCr 2.29TCr 2.24TCr 97TCr | EV / Sales 2024 |
-
| EV / Sales 2025 | 23,18,10,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 3 months | +1.89% | ||
| 6 months | +65.31% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 15.01 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/06/26 | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -1,99,63,157 | 12.9020% | |
| 01/05/26 | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 02/02/26 | Free | Chief Financial Officer | 2,26,000 | 0.1691% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +134.38% | +533.80% | 626.65Cr | |
| -0.05% | +3.98% | +3.17% | +24.49% | 5.12TCr | |
| -1.36% | +4.82% | +485.55% | +614.84% | 4.54TCr | |
| -2.04% | +3.69% | +19.34% | +91.23% | 4.2TCr | |
| +2.72% | +6.02% | +33.33% | +19.66% | 4.21TCr | |
| 0.00% | -3.91% | +18.49% | +47.98% | 3.19TCr | |
| -1.85% | +3.48% | - | - | 1.67TCr | |
| +0.72% | +5.27% | +31.55% | +145.37% | 1.71TCr | |
| -0.74% | +2.61% | +6.29% | +34.45% | 1.48TCr | |
| +0.50% | +3.62% | +82.64% | +46.53% | 1.39TCr | |
| Average | -0.13% | +3.10% | +90.53% | +173.15% | 2.81TCr | |
| Weighted average by Cap. | -0.18% | +3.15% | +104.38% | +159.93% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 12.84 11.98 11 20.66 1.44T 21.07 142.15 55.41 719.3 56.32 55.1 2.38T |
| Net income | -24Cr -20Cr -19Cr -17Cr -32Cr -2.26TCr -33Cr -223.42Cr -87Cr -1.13TCr -89Cr -87Cr -3.74TCr | -20Cr -17Cr -16Cr -14Cr -27Cr -1.89TCr -28Cr -187.2Cr -73Cr -947.23Cr -74Cr -73Cr -3.14TCr |
| Net Debt | -36Cr -31Cr -29Cr -27Cr -50Cr -3.49TCr -51Cr -345.29Cr -134.6Cr -1.75TCr -136.81Cr -133.83Cr -5.78TCr | -18Cr -15Cr -14Cr -13Cr -24Cr -1.69TCr -25Cr -166.98Cr -65Cr -844.93Cr -66Cr -65Cr -2.8TCr |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
